The association between weight at birth and breast cancer risk revisited using Mendelian randomisation.

Birth Weight / genetics Breast Neoplasms / epidemiology Female Humans Mendelian Randomization Analysis Polymorphism, Single Nucleotide Risk Assessment
Birth weight Breast cancer Mendelian randomisation

Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 10 09 2018
accepted: 19 01 2019
pubmed: 10 2 2019
medline: 29 9 2019
entrez: 10 2 2019
Statut: ppublish

Résumé

Observational studies suggest that higher birth weight (BW) is associated with increased risk of breast cancer in adult life. We conducted a two-sample Mendelian randomisation (MR) study to assess whether this association is causal. Sixty independent single nucleotide polymorphisms (SNPs) known to be associated at P < 5 × 10

Identifiants

DOI: 10.1007/s10654-019-00485-7 PMID: 30737679 PMC: PMC6497616
pubmed: 30737679
doi: 10.1007/s10654-019-00485-7
pii: 10.1007/s10654-019-00485-7
pmc: PMC6497616
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

591-600

Subventions

Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/13/13/30194
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-1214-20016
Pays : United Kingdom
Organisme : Department of Health
ID : RP-PG-0707-10031
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/7
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 204623/Z/16/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RG/18/13/33946
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom

Références

Am J Epidemiol. 2000 Dec 15;152(12):1121-8
pubmed: 11130617
J Natl Cancer Inst. 2001 Jan 3;93(1):60-2
pubmed: 11136844
Br J Cancer. 2002 Jan 7;86(1):84-8
pubmed: 11857016
Br J Cancer. 2002 Jan 7;86(1):89-91
pubmed: 11857017
Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):207-10
pubmed: 11867509
Breast Cancer Res. 2003;5(1):42-4
pubmed: 12559045
Cancer Causes Control. 2003 Feb;14(1):61-4
pubmed: 12708726
Br J Cancer. 2003 Nov 3;89(9):1664-6
pubmed: 14583767
Br J Cancer. 2004 Aug 2;91(3):519-24
pubmed: 15266328
N Engl J Med. 2004 Oct 14;351(16):1619-26
pubmed: 15483280
Breast Cancer Res. 2004;6(6):R656-67
pubmed: 15535848
Int J Cancer. 2005 Apr 10;114(3):461-4
pubmed: 15551343
Breast Cancer Res. 2005;7(1):13-7
pubmed: 15642176
Int J Cancer. 2005 Jul 1;115(4):611-7
pubmed: 15700315
Br J Cancer. 2006 Jun 5;94(11):1734-7
pubmed: 16641898
Carcinogenesis. 2006 Dec;27(12):2464-8
pubmed: 16777984
Int J Cancer. 2006 Nov 1;119(9):2007-25
pubmed: 16823839
Breast Cancer Res. 2007;9(3):R29
pubmed: 17501995
Breast Cancer Res. 2007;9(4):109
pubmed: 17688678
Br J Cancer. 2008 Feb 12;98(3):660-3
pubmed: 18256588
PLoS Med. 2008 Sep 30;5(9):e193
pubmed: 18828667
Bioinformatics. 2008 Dec 15;24(24):2938-9
pubmed: 18974171
Br J Cancer. 2009 Jun 2;100(11):1794-8
pubmed: 19417744
Lancet. 1990 Apr 21;335(8695):939-40
pubmed: 1970028
Stat Methods Med Res. 2012 Jun;21(3):223-42
pubmed: 21216802
Ann Oncol. 2012 Jan;23(1):245-50
pubmed: 21515664
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
Breast Cancer Res. 2014 Jan 20;16(1):R4
pubmed: 24443815
Int J Epidemiol. 2014 Jun;43(3):922-9
pubmed: 24608958
Eur J Epidemiol. 2014 May;29(5):343-51
pubmed: 24848607
Cancer Epidemiol. 2014 Oct;38(5):538-43
pubmed: 25096278
Nature. 2014 Oct 02;514(7520):92-97
pubmed: 25231870
Hum Mol Genet. 2015 Feb 15;24(4):1155-68
pubmed: 25281659
Nat Genet. 2014 Nov;46(11):1173-86
pubmed: 25282103
Am J Epidemiol. 2015 Feb 15;181(4):251-60
pubmed: 25632051
Am J Epidemiol. 2015 Feb 15;181(4):290-1
pubmed: 25660081
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413
Stat Med. 2015 Sep 20;34(21):2926-40
pubmed: 25950993
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Nat Genet. 2015 Nov;47(11):1294-1303
pubmed: 26414677
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Diabetologia. 2016 Sep;59(9):1920-7
pubmed: 27333884
Int J Epidemiol. 2016 Oct;45(5):1600-1616
pubmed: 27342221
Diabetes. 2016 Oct;65(10):3002-7
pubmed: 27402723
PLoS Med. 2016 Aug 23;13(8):e1002105
pubmed: 27551723
Nature. 2016 Oct 13;538(7624):248-252
pubmed: 27680694
Nat Genet. 2016 Dec;48(12):1462-1472
pubmed: 27798627
Int J Epidemiol. 2017 Dec 1;46(6):1734-1739
pubmed: 28398548
Diabetes. 2017 Nov;66(11):2888-2902
pubmed: 28566273
Stat Med. 2017 Dec 20;36(29):4705-4718
pubmed: 28960498
Int J Epidemiol. 2017 Dec 1;46(6):1985-1998
pubmed: 29040600
Nature. 2017 Nov 2;551(7678):92-94
pubmed: 29059683
Circ Genom Precis Med. 2018 Jun;11(6):e002054
pubmed: 29875125
Epidemiology. 1996 Jan;7(1):34-7
pubmed: 8664398
Lancet. 1996 Dec 7;348(9041):1542-6
pubmed: 8950880
J Natl Cancer Inst. 1997 Jan 1;89(1):71-6
pubmed: 8978409
Paediatr Perinat Epidemiol. 1998 Oct;12(4):397-407
pubmed: 9805713

Auteurs

Siddhartha P Kar (SP)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. sk718@medschl.cam.ac.uk.
Homerton College, Hills Road, Cambridge, CB2 8PH, UK. sk718@medschl.cam.ac.uk.
ORCID: 0000-0002-2314-1426

Irene L Andrulis (IL)

Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.

Hermann Brenner (H)

Division of Clinical Epidemiology and Ageing Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Stephen Burgess (S)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.

Jenny Chang-Claude (J)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Cancer Epidemiology, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg (UCCH), Hamburg, Germany.

Daniel Considine (D)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

Thilo Dörk (T)

Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.

Dafydd Gareth R Evans (DGR)

Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

Manuela Gago-Domínguez (M)

Genomic Medicine Group, Galician Foundation of Genomic Medicine, Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saude (SERGAS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago De Compostela, Spain.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Graham G Giles (GG)

Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
Center for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

Mikael Hartman (M)

Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
Department of Surgery, National University of Singapore, Singapore, Singapore.

Dezheng Huo (D)

Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jingmei Li (J)

Human Genetics, Genome Institute of Singapore, Singapore, Singapore.

Artitaya Lophatananon (A)

Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Sara Margolin (S)

Department of Oncology, Södersjukhuset and Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Roger L Milne (RL)

Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
Center for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.

Kenneth R Muir (KR)

Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

Håkan Olsson (H)

Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.

Kevin Punie (K)

Department of Oncology, Leuven Multidisciplinary Breast Centre, University Hospital Leuven, KU Leuven, Louvain, Belgium.

Paolo Radice (P)

Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.

Jacques Simard (J)

Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Quebec City, QC, Canada.

Rulla M Tamimi (RM)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Els Van Nieuwenhuysen (E)

Department of Oncology, Leuven Multidisciplinary Breast Centre, University Hospital Leuven, KU Leuven, Louvain, Belgium.

Camilla Wendt (C)

Department of Oncology, Södersjukhuset and Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.

Wei Zheng (W)

Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.

Paul D P Pharoah (PDP)

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Department of Oncology, University of Cambridge, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Mensurations corporelles › Poids › Poids de naissance › The association between weight at birth and...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › The association between weight at birth and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The association between weight at birth and...
questionsmedicales.fr › Techniques d'investigation › Analyse de randomisation mendélienne › The association between weight at birth and...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Polymorphisme génétique › Polymorphisme de nucléotide simple › The association between weight at birth and...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › The association between weight at birth and...